Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Sep 26;4(6):884-886.
doi: 10.1002/mdc3.12535. eCollection 2017 Nov-Dec.

Isolated Nocturnal Occurrence of Orofacial Dyskinesias in N-methyl-D-aspartate Receptor Encephalitis-A New Diagnostic Clue

Affiliations
Case Reports

Isolated Nocturnal Occurrence of Orofacial Dyskinesias in N-methyl-D-aspartate Receptor Encephalitis-A New Diagnostic Clue

Hugo Morales-Briceño et al. Mov Disord Clin Pract. .

Abstract

Background: The syndrome of anti-N-methyl-D-aspartate receptor encephalitis is classically associated with a combination of limbic dysfunction, dysautonomia, central hypoventilation and movement disorders. On clinical grounds, the diagnosis is often supported by the presence of generalized dyskinesias in a patient with encephalopathy and catatonic signs. Orofacial dyskinesias have been recognized as characteristic of the disorder but can be absent in some patients. Pure psychiatric syndromes without movement disorders have also been described.

Methods and results: The authors describe 2 male patients who presented with prominent neuropsychiatric symptoms without movement disorders during wakefulness but isolated orofacial dyskinesias during sleep. In 1 patient, this observation supported the early introduction of immunotherapy; and, in both patients, the clinical outcome was excellent.

Conclusions: Careful history and nocturnal examination may reveal orofacial dyskinesias in patients with N-methyl-D-aspartate receptor encephalitis who have apparent pure psychiatric manifestations.

Keywords: N‐methyl‐D‐aspartate (NMDA) receptor encephalitis; autoimmune encephalitis; orofacial dyskinesias.

PubMed Disclaimer

References

    1. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti‐NMDA‐receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091–1098. - PMC - PubMed
    1. Kayser MS, Titulaer MJ, Gresa‐Arribas N, Dalmau J. Frequency and characteristics of isolated psychiatric episodes in anti‐N‐methyl‐d‐aspartate receptor encephalitis. JAMA Neurol 2013;70:1133–1139. - PMC - PubMed
    1. Irani SR, Bera K, Waters P, et al. N‐methyl‐D‐aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non‐paraneoplastic disorder of both sexes. Brain 2010;133:1655–1667. - PMC - PubMed
    1. Gable M, Glaser C. Anti‐N‐methyl‐D‐aspartate receptor encephalitis appearing as a new‐onset psychosis: disease course in children and adolescents within the California Encephalitis Project. Pediatr Neurol 2017;72:25–30. - PubMed
    1. Moscato EH, Peng X, Jain A, Parsons TD, Dalmau J, Balice‐Gordon RJ. Acute mechanisms underlying antibody effects in anti‐N‐methyl‐D‐aspartate receptor encephalitis. Ann Neurol 2014;76:108–119. - PMC - PubMed

Publication types

LinkOut - more resources